Payment overview · 2025
General Payments
$121.59
5 reported records · 5 companies
Healthcare provider profile · identity verified
Steven Hanberg, MD
Allopathic & Osteopathic Physicians|Internal Medicine · ELKHART, IN · NPI 1821180381
Verified facts
What the public records show
CMS Open Payments records show Steven Hanberg, MD received $121.59 in general payments during 2025 across 5 reported records.
SUN PHARMACEUTICAL INDUSTRIES INC. accounted for 36.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 399 claims for Synthroid by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 159 claims for Jardiance by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 456 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NURTEC ODT as an associated drug or biological on 217574 records involving 54025 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Nurtec Odt by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | Unresolved — no canonical attribution shown | $44.62 | 36.7% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $23.12 | 19.0% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $21.19 | 17.4% | 1 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $18.85 | 15.5% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $13.81 | 11.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $102.74 | 4 |
| Education | $18.85 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $23.12 | 1 | 2025 |
Source payment records
|
|||||
| DALVANCE Normalized: dalvance |
Drug | ABBVIE INC. | $21.19 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $21.19 | 1 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $18.85 | 1 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $13.81 | 1 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $13.81 | 1 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $13.81 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 159 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
399 | 53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
159 | 33 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
456 | 72 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | NURTEC ODT open payments reported associated product |
CMS Open Payments — General Payments 217574 supporting records · 54025 recipient NPIs · example record 1228794063 |
Nurtec Odt · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
15 | 15 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1215 | 316 |
| Amlodipine Besylate | Amlodipine Besylate | 898 | 206 |
| Losartan Potassium | Losartan Potassium | 576 | 149 |
| Levothyroxine Sodium | Levothyroxine Sodium | 531 | 106 |
| Eliquis | Apixaban | 456 | 72 |
| Synthroid | Levothyroxine Sodium | 399 | 53 |
| Omeprazole | Omeprazole | 361 | 98 |
| Potassium Chloride | Potassium Chloride | 355 | 75 |
| Tamsulosin Hcl | Tamsulosin Hcl | 339 | 70 |
| Gabapentin | Gabapentin | 290 | 73 |
| Furosemide | Furosemide | 285 | 60 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 277 | 100 |
| Mounjaro | Tirzepatide | 254 | 52 |
| Metoprolol Tartrate | Metoprolol Tartrate | 231 | 47 |
| Sertraline Hcl | Sertraline Hcl | 213 | 41 |
| Lisinopril | Lisinopril | 207 | 48 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 204 | 47 |
| Pantoprazole Sodium | Pantoprazole Sodium | 204 | 56 |
| Metoprolol Succinate | Metoprolol Succinate | 197 | 57 |
| Clopidogrel | Clopidogrel Bisulfate | 190 | 43 |
| Metformin Hcl Er | Metformin Hcl | 189 | 39 |
| Ezetimibe | Ezetimibe | 177 | 47 |
| Trazodone Hcl | Trazodone Hcl | 173 | 52 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 171 | 47 |
| Carvedilol | Carvedilol | 163 | 40 |
| Jardiance | Empagliflozin | 159 | 33 |
| Donepezil Hcl | Donepezil Hcl | 158 | 37 |
| Famotidine | Famotidine | 154 | 39 |
| Metformin Hcl | Metformin Hcl | 151 | 35 |
| Levetiracetam | Levetiracetam | 148 | 25 |
| Duloxetine Hcl | Duloxetine Hcl | 142 | 36 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 142 | 39 |
| Chlorthalidone | Chlorthalidone | 135 | 33 |
| Escitalopram Oxalate | Escitalopram Oxalate | 131 | 27 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 128 | 40 |
| Citalopram Hbr | Citalopram Hydrobromide | 123 | 42 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 122 | 31 |
| Fluticasone Propionate | Fluticasone Propionate | 117 | 46 |
| Ozempic | Semaglutide | 103 | 17 |
| Xarelto | Rivaroxaban | 100 | suppressed |
| Nystatin | Nystatin | 96 | 43 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 94 | 30 |
| Ondansetron Odt | Ondansetron | 88 | 27 |
| Mirtazapine | Mirtazapine | 84 | 28 |
| Montelukast Sodium | Montelukast Sodium | 84 | 24 |
| Doxycycline Hyclate | Doxycycline Hyclate | 82 | 60 |
| Quetiapine Fumarate | Quetiapine Fumarate | 82 | 23 |
| Bupropion Xl | Bupropion Hcl | 81 | 21 |
| Baclofen | Baclofen | 78 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 78 | 24 |
| Allopurinol | Allopurinol | 77 | 19 |
| Alprazolam | Alprazolam | 75 | 18 |
| Farxiga | Dapagliflozin Propanediol | 75 | 11 |
| Lorazepam | Lorazepam | 75 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 74 | 19 |
| Divalproex Sodium | Divalproex Sodium | 72 | 17 |
| Finasteride | Finasteride | 71 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 70 | 25 |
| Simvastatin | Simvastatin | 69 | 16 |
| Vascepa | Icosapent Ethyl | 68 | suppressed |
| Prednisone | Prednisone | 66 | 34 |
| Atropine Sulfate | Atropine Sulfate | 65 | suppressed |
| Hydrocortisone | Hydrocortisone | 65 | 14 |
| Cephalexin | Cephalexin | 62 | 27 |
| Spiriva Respimat | Tiotropium Bromide | 62 | 17 |
| Clonidine Hcl | Clonidine Hcl | 61 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 60 | 12 |
| Spironolactone | Spironolactone | 59 | 20 |
| Latanoprost | Latanoprost | 58 | 14 |
| Memantine Hcl | Memantine Hcl | 57 | 16 |
| Hydrochlorothiazide | Hydrochlorothiazide | 55 | 11 |
| Midodrine Hcl | Midodrine Hcl | 55 | 22 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 54 | 18 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 53 | 15 |
| Humalog Kwikpen U-100 | Insulin Lispro | 52 | 16 |
| Alendronate Sodium | Alendronate Sodium | 51 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 51 | 21 |
| Levemir Flexpen | Insulin Detemir | 49 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 48 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 47 | 11 |
| Lamotrigine | Lamotrigine | 46 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 46 | 22 |
| Amitriptyline Hcl | Amitriptyline Hcl | 43 | 14 |
| Lactulose | Lactulose | 43 | 21 |
| Pravastatin Sodium | Pravastatin Sodium | 43 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 43 | 20 |
| Ipratropium Bromide | Ipratropium Bromide | 42 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 41 | 12 |
| Tresiba Flextouch U-100 | Insulin Degludec | 41 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 41 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 39 | suppressed |
| Myrbetriq | Mirabegron | 38 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 38 | suppressed |
| Rezvoglar Kwikpen | Insulin Glargine-Aglr | 38 | 17 |
| Entresto | Sacubitril/Valsartan | 37 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 37 | suppressed |
| Olanzapine | Olanzapine | 36 | suppressed |
| Colchicine | Colchicine | 34 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 34 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 34 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 33 | suppressed |
| Trulicity | Dulaglutide | 33 | suppressed |
| Januvia | Sitagliptin Phosphate | 31 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 31 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 31 | suppressed |
| Cefdinir | Cefdinir | 30 | 23 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 30 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 30 | suppressed |
| Insulin Lispro | Insulin Lispro | 29 | 14 |
| Irbesartan | Irbesartan | 29 | suppressed |
| Meloxicam | Meloxicam | 29 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 29 | 17 |
| Atropine Sulfate | Atropine Sulfate/Pf | 28 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 28 | suppressed |
| Loperamide | Loperamide Hcl | 28 | 11 |
| Tradjenta | Linagliptin | 28 | suppressed |
| Valsartan | Valsartan | 28 | suppressed |
| Klor-Con M20 | Potassium Chloride | 27 | suppressed |
| Novolog Flexpen | Insulin Aspart | 27 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 27 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 27 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 27 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 26 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 26 | 11 |
| Ketoconazole | Ketoconazole | 26 | suppressed |
| Lovastatin | Lovastatin | 26 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 26 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 25 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 24 | suppressed |
| Aripiprazole | Aripiprazole | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 23 | suppressed |
| Paxlovid (Eua) | Nirmatrelvir/Ritonavir | 23 | 23 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 22 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 22 | suppressed |
| Ibuprofen | Ibuprofen | 22 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 22 | 11 |
| Methylprednisolone | Methylprednisolone | 22 | 16 |
| Pregabalin | Pregabalin | 22 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 21 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 20 | 15 |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 20 | 13 |
| Nifedipine Er | Nifedipine | 20 | suppressed |
| Primidone | Primidone | 20 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 19 | suppressed |
| Glimepiride | Glimepiride | 19 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 15 |
| Oxycodone Hcl | Oxycodone Hcl | 19 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 18 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 18 | suppressed |
| Klor-Con 10 | Potassium Chloride | 18 | suppressed |
| Levalbuterol Hcl | Levalbuterol Hcl | 18 | suppressed |
| Mupirocin | Mupirocin | 18 | 11 |
| Nurtec Odt | Rimegepant Sulfate | 18 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 18 | suppressed |
| Amantadine | Amantadine Hcl | 17 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 17 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 17 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 17 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 17 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 17 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 17 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 17 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | 11 |
| Gvoke Hypopen 1-Pack | Glucagon | 16 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 16 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Temazepam | Temazepam | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Wegovy | Semaglutide | 16 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 15 | suppressed |
| Erythromycin | Erythromycin Base | 15 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 15 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 15 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 15 | 15 |
| Combigan | Brimonidine Tartrate/Timolol | 14 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Fentanyl | Fentanyl | 14 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 14 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | suppressed |
| Otezla | Apremilast | 14 | suppressed |
| Rexulti | Brexpiprazole | 14 | suppressed |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 14 | suppressed |
| Scopolamine | Scopolamine | 14 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 14 | suppressed |
| Avonex Pen (4 Pack) | Interferon Beta-1a | 13 | suppressed |
| Diazepam | Diazepam | 13 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Levocarnitine | Levocarnitine | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Verapamil Sr | Verapamil Hcl | 13 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Folic Acid | Folic Acid | 12 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 12 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 11 | 11 |
| Atenolol | Atenolol | 11 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 11 | suppressed |
| Dofetilide | Dofetilide | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 11 | suppressed |
| Paliperidone Er | Paliperidone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $121.59 · 5 records | SUN PHARMACEUTICAL INDUSTRIES INC. | ABRYSVO, COMIRNATY, DALVANCE, FREESTYLE LIBRE 3, JARDIANCE, PREVNAR 20, UBRELVY | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error